Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000078003-22-000006
Filing Date
2022-02-11
Accepted
2022-02-11 15:54:39
Documents
1
Group Members
PFIZER VENTURES (US) LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A 4D MOLECULAR a4dm_13gax2x22f.htm SC 13G/A 60948
  Complete submission text file 0000078003-22-000006.txt   62703
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filed by) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Subject) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91921 | Film No.: 22620438
SIC: 2836 Biological Products, (No Diagnostic Substances)